356 related articles for article (PubMed ID: 11077850)
1. [Maxaquin in the combined treatment of tuberculosis].
Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
[TBL] [Abstract][Full Text] [Related]
2. [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
Mar'iandyshev AO; Klinberg NM; Shonbina AI; Moroz MI
Probl Tuberk; 1997; (4):19-21. PubMed ID: 9333808
[TBL] [Abstract][Full Text] [Related]
3. [Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
Mishin VIu; Vasil'eva IA; Martynova LP
Probl Tuberk; 1999; (6):20-2. PubMed ID: 10715950
[No Abstract] [Full Text] [Related]
4. [Bactericidal effects of maxaquin on mycobacterium tuberculosis].
Kunichian AD; Mozhokina GN; Sokolova GB; Shapatava MN
Probl Tuberk; 1997; (1):53-4. PubMed ID: 9162930
[TBL] [Abstract][Full Text] [Related]
5. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
Padeĭskaia EN
Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101
[No Abstract] [Full Text] [Related]
6. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
7. How are we creating fluoroquinolone-resistant tuberculosis?
Bernardo J; Yew WW
Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
[No Abstract] [Full Text] [Related]
8. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Singla R; Gupta S; Gupta R; Arora VK
Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
11. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective].
Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa
Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177
[No Abstract] [Full Text] [Related]
12. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
Tomioka H; Sato K; Saito H
Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
[No Abstract] [Full Text] [Related]
13. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
14. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.
Törün T; Tahaoğlu K; Ozmen I; Sevim T; Ataç G; Kir A; Güngör G; Bölükbaşi Y; Maden E
Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
El'kun GB
Vestn Otorinolaringol; 1999; (6):45-6. PubMed ID: 10596605
[No Abstract] [Full Text] [Related]
16. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
17. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
18. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
19. [Long-term results of treatment of drug-resistant pulmonary tuberculosis in adolescents].
Firsova VA; Poluĕktova FG; Ryzhova AP
Probl Tuberk Bolezn Legk; 2005; (7):25-8. PubMed ID: 16130423
[TBL] [Abstract][Full Text] [Related]
20. Saving quinolones for tuberculosis.
Bedi RS
J Assoc Physicians India; 2003 Sep; 51():933-4. PubMed ID: 14710994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
